EnVVeno Competitors
| NVNO Stock | USD 8.67 0.65 6.97% |
EnVVeno Medical vs ProPhase Labs Correlation
Poor diversification
The correlation between enVVeno Medical Corp and PRPH is 0.64 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding enVVeno Medical Corp and PRPH in the same portfolio, assuming nothing else is changed.
Moving against EnVVeno Stock
| 0.6 | DXCM | DexCom Inc | PairCorr |
| 0.55 | EDAP | EDAP TMS SA | PairCorr |
| 0.38 | EKSO | Ekso Bionics Holdings Upward Rally | PairCorr |
| 0.35 | ELMD | Electromed Earnings Call Today | PairCorr |
| 0.33 | 7D2A | SEDANA MEDICAL AB | PairCorr |
EnVVeno Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between EnVVeno Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of EnVVeno and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of enVVeno Medical Corp does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between EnVVeno Stock performing well and EnVVeno Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze EnVVeno Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ALUR | 5.78 | (0.58) | 0.00 | (0.11) | 0.00 | 16.54 | 40.95 | |||
| AEMD | 5.40 | (0.99) | 0.00 | (1.83) | 0.00 | 10.51 | 38.52 | |||
| CODX | 5.96 | (1.66) | 0.00 | (0.76) | 0.00 | 9.88 | 75.41 | |||
| VVOS | 3.32 | (0.75) | 0.00 | (0.52) | 0.00 | 5.29 | 31.84 | |||
| COCH | 5.07 | 0.13 | 0.02 | 0.17 | 5.66 | 10.29 | 90.44 | |||
| EKSO | 6.20 | 1.46 | 0.24 | 0.62 | 5.46 | 10.72 | 112.11 | |||
| ADGM | 4.92 | 0.55 | 0.07 | (0.67) | 5.48 | 11.36 | 64.48 | |||
| AYTU | 2.70 | 0.03 | 0.00 | 0.09 | 3.66 | 4.69 | 16.84 | |||
| GOVX | 5.87 | (2.79) | 0.00 | (0.94) | 0.00 | 9.38 | 42.89 | |||
| PRPH | 8.32 | (3.55) | 0.00 | (9.79) | 0.00 | 15.47 | 77.27 |
Cross Equities Net Income Analysis
Compare enVVeno Medical Corp and related stocks such as Allurion Technologies, Aethlon Medical, and Co Diagnostics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALUR | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (12.4 M) | (37.7 M) | (80.6 M) | (26.1 M) | (23.5 M) | (24.7 M) |
| AEMD | (1.5 K) | (8.1 M) | (4.9 M) | (13.4 M) | (6.8 M) | (4.9 M) | (7.3 M) | (5.7 M) | (6.2 M) | (6.4 M) | (7.8 M) | (10.4 M) | (12 M) | (12.2 M) | (13.4 M) | (12 M) | (11.4 M) |
| CODX | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (2 M) | (1.9 M) | (7 M) | (6.3 M) | (6.2 M) | 42.5 M | 36.7 M | (14.2 M) | (35.3 M) | (37.6 M) | (33.9 M) | (32.2 M) |
| VVOS | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (10.8 M) | (12.1 M) | (20.3 M) | (23.8 M) | (13.6 M) | (11.1 M) | (10 M) | (10.5 M) |
| COCH | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (8.7 M) | (15.9 M) | (29.9 M) | (20.8 M) | (18.7 M) | (19.7 M) |
| EKSO | (15 M) | (15 M) | (15 M) | (12.3 K) | (33.8 M) | (19.6 M) | (23.5 M) | (29.1 M) | (27 M) | (12.1 M) | (15.8 M) | (9.8 M) | (15.1 M) | (15.2 M) | (11.3 M) | (13 M) | (13.7 M) |
| ADGM | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (19.9 M) | (23.7 M) | (38.1 M) | (53.8 M) | (48.4 M) | (46 M) |
| AYTU | (49 K) | (59.7 K) | (57.3 K) | (5.6 M) | (7.7 M) | (28.2 M) | (22.5 M) | (10.2 M) | (47.2 M) | (13.6 M) | (58.3 M) | (108.8 M) | (17.1 M) | (15.8 M) | (13.6 M) | (12.2 M) | (12.8 M) |
| GOVX | 36.7 M | (2.3 M) | (2.1 M) | (2.3 M) | (2.7 M) | (2.7 M) | (3.3 M) | (2.2 M) | (2.6 M) | (2.4 M) | (2.9 M) | (18.5 M) | (14 M) | (26 M) | (25 M) | (22.5 M) | (21.4 M) |
| PRPH | (700 K) | (2.7 M) | (1.1 M) | 405 K | (7.8 M) | (3.6 M) | (2.9 M) | 41.8 M | (1.7 M) | (3.1 M) | (2.1 M) | 6.3 M | 18.5 M | (16.8 M) | (53.4 M) | (48 M) | (45.6 M) |
enVVeno Medical Corp and related stocks such as Allurion Technologies, Aethlon Medical, and Co Diagnostics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in enVVeno Medical Corp financial statement analysis. It represents the amount of money remaining after all of enVVeno Medical Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.EnVVeno Medical Competitive Analysis
The better you understand EnVVeno Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, EnVVeno Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across EnVVeno Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
EnVVeno Medical Competition Performance Charts
Five steps to successful analysis of EnVVeno Medical Competition
EnVVeno Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by enVVeno Medical Corp in relation to its competition. EnVVeno Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of EnVVeno Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact EnVVeno Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to enVVeno Medical Corp, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your EnVVeno Medical position
In addition to having EnVVeno Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Currency Funds Thematic Idea Now
Currency Funds
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out EnVVeno Medical Correlation with its peers. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Health Care Equipment & Supplies sector continue expanding? Could EnVVeno diversify its offerings? Factors like these will boost the valuation of EnVVeno Medical. Anticipated expansion of EnVVeno directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every EnVVeno Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding enVVeno Medical Corp requires distinguishing between market price and book value, where the latter reflects EnVVeno's accounting equity. The concept of intrinsic value - what EnVVeno Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push EnVVeno Medical's price substantially above or below its fundamental value.
It's important to distinguish between EnVVeno Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EnVVeno Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EnVVeno Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.